Point72 Asset Management’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
Other funds holding EPZM
RM
NM
RSCM
PAI
PIM
RCMNY
WP
Point72 Asset Management's EPZM Position: Q2 2022 in Review
Point72 Asset Management sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 2,500,000 shares — an estimated $2.88M sold.
Point72 Asset Management first reported a position in EPZM in Q3 2014 and held it in 13 quarters. The position peaked at $17.6M in Q3 2017. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.
- Point72 Asset Management reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
- Point72 Asset Management sold 2,500,000 Epizyme, Inc shares in Q2 2022, an estimated $2.88M.
- Point72 Asset Management first reported a position in Epizyme, Inc in Q3 2014 and held it in 13 quarters.
- Point72 Asset Management's Epizyme, Inc position peaked at $17.6M in Q3 2017.
- 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.
Based on Point72 Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.